查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2001255

体外诊断试剂（IVD）市场报告：趋势、预测与竞争分析（至2035年）

Animal IVD Market Report: Trends, Forecast and Competitive Analysis to 2035
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球动物体外诊断（IVD）市场前景广阔，宠物医院、畜牧和兽医医疗系统、动物园、科研机构的动物试验中心以及动植物检疫部门都将迎来发展机会。预计2026年至2035年，全球动物IVD市场将以7.8%的复合年增长率成长，到2035年市场规模预计将达到100亿美元。推动该市场成长要素包括：动物健康检查需求的不断增长、通用病和感染疾病的蔓延感染疾病即时检测技术的日益普及。

  • 根据 Lucintel 的预测，在各种检测类型中，免疫学诊断预计在预测期内将呈现更高的成长率。
  • 从应用领域来看，畜牧业和兽医业预计将呈现最高的成长率。
  • 按地区划分，预计亚太地区在预测期内将呈现最高的成长率。

兽医体外诊断市场的新趋势

受技术进步、宠物饲养量增加以及人们对动物健康日益关注的推动，动物体外诊断（IVD）市场正经历快速成长。随着兽医领域采用创新诊断工具，市场变得更加活跃和竞争激烈。这些趋势正在改变兽医诊断和治疗动物疾病的方式，从而改善动物健康状况并提高临床实践效率。新技术的整合和应用范围的扩大也为市场相关人员创造了新的机会。对于希望把握不断变化的市场格局并满足日益增长的先进兽医诊断需求的相关人员而言，了解这些新兴趋势至关重要。

  • 诊断工具的技术创新：分子诊断、即时检测和数位影像等诊断技术正取得显着进展。这些创新使疾病检测更加快速且准确，提高了临床决策的精准度。携带式、易用型设备在兽医院的普及率不断提高，提升了检测的可及性，并缩短了等待检测结果的时间。人工智慧 (AI) 和机器学习的融合进一步提升了诊断的准确性。这些技术进步透过拓展可检测疾病的范围和改善诊断流程，推动了市场成长，最终改善了动物健康管理。
  • 宠物饲养量的增加和宠物「拟人化」趋势：在全球范围内，尤其是在都市区，宠物数量不断增长，推动了对先进兽医诊断技术的需求。宠物饲主越来越关注宠物的健康，并寻求全面的健康检查和疾病的早期检测。宠物「拟人化」的趋势增加了兽医护理（包括诊断）方面的支出。这种转变促使兽医诊所采用先进的诊断工具来满足客户的期望。因此，满足那些将宠物视为家庭成员的饲主需求的市场正在不断增长，这也推动了体外诊断（IVD）解决方案的需求。
  • 动物疾病日益增多：动物感染疾病和慢性病发病率的不断上升是推动市场发展的主要因素。寄生虫感染疾病、通用感染疾病和代谢紊乱等疾病需要准确快速的诊断才能有效治疗。除了这些疾病的盛行率不断上升外，对疾病监测和控制日益增长的需求也促使兽医医院和实验室投资先进的诊断解决方案。在牲畜密度高、宠物饲养率高的地区，这趋势尤其明显。对可靠的诊断测试的需求，以管理和预防疾病爆发，极大地促进了市场扩张。
  • 监管趋势与标准化：不断演进的法规结构和对品质标准的日益重视正在重塑市场格局。各国政府和监管机构正在实施更严格的兽医诊断指南，以确保其安全性、有效性和可靠性。这促使研发投入增加，并推动新诊断产品的核准。标准化工作也促进了创新解决方案的国际贸易和市场准入。这些监管方面的进步正在创造一个更可靠和更具竞争力的市场环境，鼓励製造商开发符合国际标准的高品质、受监管产品。
  • 即时检测（POC​​T）的扩展：即时检测的引入正在革新兽医诊断，实现了快速、现场疾病检测。 POCT设备便携易用，并能立即提供结果，使其在紧急情况和偏远地区至关重要。这一趋势对畜牧管理的影响尤其显着，因为快速决策可以有效防止疾病传播。 POCT的便利性和速度也有助于提高客户满意度和兽医医院的营运效率。随着技术的进步和成本的降低，POCT有望成为兽医诊断的标准组成部分，从而显着扩大其市场覆盖范围和应用领域。

这些新趋势正透过提高诊断准确性、扩大服务范围和加强疾病管理，重塑整个动物体外诊断市场。技术创新、消费者行为的改变、疾病流行、监管支援以及即时检测的兴起，都在推动和改变市场成长。这些进步使得兽医照护更加积极主动、高效精准，最终有助于提升动物健康和福利，并为市场扩张开闢新的途径。

兽用静脉注射疾病（IVD）市场的最新趋势

受技术进步、宠物饲养量增加以及人们对动物健康日益关注的推动，动物体外诊断（IVD）市场正经历快速成长。诊断工具的创新使得疾病检测更加快速且精准，进而改善了治疗效果。不断扩大的市场为製造商和服务供应商带来了巨大的机会。随着人们对通用感染疾病的认识不断提高，对可靠诊断解决方案的需求也随之激增。这种变化正在重塑兽医服务的提供方式，更加重视早期诊断和个人化治疗方案。

  • 诊断工具的技术创新：先进、快速、精准的诊断设备的研发正在改变兽医学。这些创新使兽医能够更早发现疾病，从而提高治疗成功率。携带式且易于使用的设备便于现场检测，并缩短了等待检测结果的时间和成本。随着技术的不断发展，预计市场将更多地采用分子诊断、数位成像和人工智慧驱动的工具，最终提高诊断准确性并扩大市场覆盖范围。
  • 宠物饲养量的增长与宠物「拟人化」趋势：全球宠物饲主数量的不断增长推动了对全面兽医诊断的需求。饲主越来越重视宠物的健康，并寻求早期准确的诊断。在宠物被视为家庭成员的都市区，这种趋势尤其明显。 「拟人化」趋势正在推动市场成长，因为饲主选择更先进的诊断服务。兽医医院和诊断检查室正在扩展服务以满足这一不断增长的需求，从而进一步加速市场扩张。
  • 通用感染疾病和慢性病日益增多：动物中通用感染疾病和慢性病的日益流行，推动了对可靠诊断解决方案的需求。早期发现莱姆病、细小病毒感染和丝虫病等疾病对于有效治疗至关重要。市场提供针对性检测和检测组合，以改善疾病管理。饲主和兽医对这些健康问题的认识不断提高，进一步推动了需求，促使诊断检测技术创新，并扩大了市场范围。
  • 监管支持与投资增加：各国政府和监管机构正透过扶持政策和资金投入来促进动物健康。对研发的投资正在推动诊断技术的创新。监管核准有助于新产品进入市场，并鼓励企业开发新的解决方案。官民合作关係和津贴也提升了市场成长前景。这种有利的环境正在吸引新参与企业，加速先进诊断技术的应用，并最终扩大整体市场规模。
  • 兽医诊断检查室及服务的扩张：兽医诊断检查室和专业服务的增加提高了人们获得先进检测服务的便利性。这些机构采用最尖端科技提供全面的诊断服务。这一扩张是由兽医医院、宠物饲主和畜牧业日益增长的需求所驱动的。实验室基础设施的完善提高了诊断速度和准确性，从而增强了客户的信任度和回头客。此类诊断服务的成长对于疾病的早期发现、治疗方案的发展以及整个市场的发展至关重要。

这些趋势的总体影响是：动物体外诊断市场蓬勃发展、不断创新且持续扩张。诊断能力的提升正在改善动物健康状况，增强市场竞争力，并创造新的机会。市场成长也有助于改善疾病管理、降低治疗成本并意识提升，最终使兽医、宠物饲主和整个行业受益。

目录

第一章执行摘要

第二章 市场概览

  • 背景与分类
  • 供应链

第三章 市场趋势与预测分析

  • 宏观经济趋势与预测
  • 产业驱动因素与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

第四章 全球动物体外诊断（IVD）市场：依类型划分

  • 吸引力分析：按类型
  • 免疫诊断
  • 临床生物化学与分子诊断
  • 血液学
  • 其他的

第五章 全球动物体外诊断（IVD）市场：依应用领域划分

  • 吸引力分析：依目的
  • 动物医院
  • 畜牧业和兽医医疗系统
  • 动物园
  • 研究机构和动物实验中心
  • 动植物检疫局
  • 其他的

第六章 区域分析

第七章：北美动物体外诊断（IVD）市场

  • 北美动物体外诊断（IVD）市场：按类型划分
  • 北美动物体外诊断（IVD）市场：按应用领域划分
  • 美国动物体外诊断（IVD）市场
  • 加拿大动物体外诊断（IVD）市场
  • 墨西哥动物体外诊断（IVD）市场

第八章：欧洲动物体外诊断试剂市场

  • 欧洲动物体外诊断（IVD）市场：按类型划分
  • 欧洲动物体外诊断（IVD）市场：依应用领域划分
  • 德国动物体外诊断试剂（IVD）市场
  • 法国动物体外诊断（IVD）试剂市场。
  • 义大利动物体外诊断（IVD）市场
  • 西班牙动物体外诊断（IVD）市场
  • 英国动物体外诊断（IVD）试剂市场

第九章：亚太地区动物体外诊断试剂（IVD）市场

  • 亚太地区体外诊断（IVD）市场：按类型划分
  • 亚太地区体外诊断（IVD）市场：依应用划分
  • 中国动物体外诊断试剂市场
  • 印度动物体外诊断试剂（IVD）市场
  • 日本动物体外诊断试剂（IVD）市场。
  • 韩国动物体外诊断（IVD）市场
  • 印尼动物体外诊断（IVD）市场

第十章：世界其他地区动物体外诊断（IVD）市场

  • 其他地区体外诊断（IVD）市场：按类型划分
  • 其他地区体外诊断（IVD）市场：依应用划分
  • 中东动物体外诊断（IVD）市场
  • 南非动物体外诊断（IVD）市场
  • 非洲动物体外诊断（IVD）市场

第十一章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析
  • 市占率分析

第十二章 机会与策略分析

  • 价值链分析
  • 成长机会分析
  • 新趋势：全球动物体外诊断（IVD）市场
  • 战略分析

第十三章：价值链中主要企业的公司概况

  • 竞争分析概述
  • Heska
  • Zoetis
  • Antech
  • Eurofins Ingenasa
  • IDEXX
  • Bio-Rad
  • Thermo Fisher Scientific
  • Randox
  • Idvet
  • Edan Instruments

第十四章附录

The future of the global animal IVD market looks promising with opportunities in the pet hospital, animal husbandry & veterinary system, zoo, research institute animal experiment center, and animal & plant quarantine department markets. The global animal IVD market is expected to reach an estimated $10 billion by 2035 with a CAGR of 7.8% from 2026 to 2035. The major drivers for this market are the increasing demand for animal health diagnostics, the rising prevalence of zoonotic & infectious diseases, and the growing adoption of point of care testing.

  • Lucintel forecasts that, within the type category, immunodiagnosis is expected to witness higher growth over the forecast period.
  • Within the application category, animal husbandry & veterinary system is expected to witness the highest growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Animal IVD Market

The animal IVD market is experiencing rapid growth driven by technological advancements, increasing pet ownership, and a rising focus on animal health. As the veterinary sector adopts innovative diagnostic tools, the market is becoming more dynamic and competitive. These developments are transforming how veterinarians diagnose and treat animal diseases, leading to improved health outcomes and more efficient clinical practices. The integration of new technologies and expanding applications are also opening new opportunities for market players. Understanding these emerging trends is essential for stakeholders aiming to capitalize on the evolving landscape and meet the growing demand for advanced veterinary diagnostics.

  • Technological Innovations in Diagnostic Tools: The market is witnessing significant advancements in diagnostic technologies such as molecular diagnostics, point-of-care testing, and digital imaging. These innovations enable faster, more accurate detection of diseases, improving clinical decision-making. Portable and user-friendly devices are increasingly being adopted in veterinary clinics, enhancing accessibility and reducing turnaround times. The integration of artificial intelligence and machine learning further enhances diagnostic precision. These technological developments are driving market growth by expanding the range of detectable conditions and improving diagnostic workflows, ultimately leading to better health management for animals.
  • Rising Pet Ownership and Humanization of Pets: Increasing pet ownership worldwide, especially in urban areas, is fueling demand for advanced veterinary diagnostics. Pet owners are now more invested in their animals health, seeking comprehensive health assessments and early disease detection. The trend toward humanization of pets has led to higher spending on veterinary care, including diagnostics. This shift is encouraging veterinary clinics to adopt sophisticated diagnostic tools to meet client expectations. As a result, the market is expanding, with more products tailored to the needs of pet owners who view their animals as family members, thereby boosting demand for IVD solutions.
  • Growing Prevalence of Animal Diseases: The rising incidence of infectious and chronic diseases in animals is a key driver for the market. Conditions such as parasitic infections, zoonoses, and metabolic disorders require accurate and timely diagnosis for effective treatment. The increasing prevalence of these diseases, coupled with the need for disease surveillance and control, is prompting veterinary clinics and laboratories to invest in advanced diagnostic solutions. This trend is particularly prominent in regions with dense livestock populations and high pet ownership. The demand for reliable diagnostic tests to manage and prevent disease outbreaks is significantly contributing to market expansion.
  • Regulatory Developments and Standardization: Evolving regulatory frameworks and increased emphasis on quality standards are shaping the market landscape. Governments and regulatory bodies are implementing stricter guidelines for veterinary diagnostics to ensure safety, efficacy, and reliability. This has led to increased investment in research and development, as well as the approval of new diagnostic products. Standardization efforts are also facilitating global trade and market entry for innovative solutions. These regulatory developments are fostering a more trustworthy and competitive market environment, encouraging manufacturers to develop high-quality, compliant products that meet international standards.
  • Expansion of Point-of-Care Testing (POCT): The adoption of point-of-care testing is revolutionizing veterinary diagnostics by enabling rapid, on-site disease detection. POCT devices are portable, easy to use, and provide immediate results, which is crucial in emergency situations and remote locations. This trend is particularly impactful in livestock management, where quick decision-making can prevent disease spread. The convenience and speed of POCT are also improving client satisfaction and operational efficiency in veterinary practices. As technology advances and costs decrease, POCT is expected to become a standard component of veterinary diagnostics, significantly expanding market reach and application scope.

These emerging trends are collectively reshaping the animal IVD market by enhancing diagnostic accuracy, expanding accessibility, and improving disease management. Technological innovations, changing consumer behaviors, disease prevalence, regulatory support, and the rise of point-of-care testing are driving growth and transforming the landscape. These developments are enabling more proactive, efficient, and precise veterinary care, ultimately benefiting animal health and welfare while opening new avenues for market expansion.

Recent Developments in the Animal IVD Market

The animal IVD market is experiencing rapid growth driven by technological advancements, increasing pet ownership, and a rising focus on animal health. Innovations in diagnostic tools are enabling quicker, more accurate disease detection, which improves treatment outcomes. The expanding market presents significant opportunities for manufacturers and service providers. As awareness about zoonotic diseases grows, demand for reliable diagnostic solutions is surging. This evolving landscape is reshaping how veterinary care is delivered, emphasizing early diagnosis and personalized treatment approaches.

  • Technological Innovations in Diagnostic Tools: The development of advanced, rapid, and accurate diagnostic devices is transforming animal healthcare. These innovations enable veterinarians to detect diseases early, improving treatment success rates. Portable and user-friendly devices facilitate on-site testing, reducing turnaround times and costs. As technology continues to evolve, the market is expected to see increased adoption of molecular diagnostics, digital imaging, and AI-powered tools, ultimately enhancing diagnostic precision and expanding market reach.
  • Rising Pet Ownership and Humanization of Pets: The increasing number of pet owners worldwide is driving demand for comprehensive veterinary diagnostics. Pet owners are investing more in their animals health, seeking early and accurate diagnoses. This trend is particularly prominent in urban areas, where pets are considered family members. The humanization trend encourages pet owners to opt for advanced diagnostic services, boosting market growth. Veterinary clinics and diagnostic labs are expanding their offerings to meet this rising demand, fostering market expansion.
  • Growing Prevalence of Zoonotic and Chronic Diseases: The rise in zoonotic diseases and chronic conditions among animals is fueling the need for reliable diagnostic solutions. Early detection of diseases like Lyme disease, parvovirus, and heartworm is critical for effective treatment. The market is responding with targeted tests and panels that improve disease management. Increased awareness among pet owners and veterinarians about these health issues is further propelling demand, leading to innovations in diagnostic assays and expanding the market scope.
  • Regulatory Support and Increased Investment: Governments and regulatory bodies are promoting animal health through supportive policies and funding. Investments in research and development are fostering innovation in diagnostic technologies. Regulatory approvals streamline market entry for new products, encouraging companies to develop novel solutions. Public-private partnerships and grants are also enhancing market growth prospects. This supportive environment is attracting new entrants and accelerating the adoption of advanced diagnostics, thereby expanding the overall market size.
  • Expansion of Veterinary Diagnostic Laboratories and Services: The proliferation of veterinary diagnostic labs and specialized services is increasing accessibility to advanced testing. These facilities are adopting cutting-edge technologies to offer comprehensive diagnostic panels. The expansion is driven by rising demand from veterinary clinics, pet owners, and livestock sectors. Enhanced laboratory infrastructure improves diagnostic turnaround times and accuracy, fostering trust and repeat business. This growth in diagnostic services is crucial for early disease detection, treatment planning, and overall market development.

The overall impact of these developments is a robust, innovative, and expanding animal IVD market. Enhanced diagnostic capabilities are improving animal health outcomes, increasing market competitiveness, and fostering new business opportunities. The markets growth is also contributing to better disease management, reduced treatment costs, and increased awareness about animal health, ultimately benefiting veterinarians, pet owners, and the industry at large.

Strategic Growth Opportunities in the Animal IVD Market

The animal IVD market is experiencing rapid expansion driven by increasing pet ownership, advancements in diagnostic technologies, and rising awareness of animal health. The demand for accurate, rapid, and cost-effective diagnostic solutions is fueling innovation and market growth. Key applications such as disease detection, wellness screening, and personalized veterinary care are creating new opportunities. Strategic investments and collaborations are further accelerating market development, making it a promising sector for stakeholders aiming to improve animal health outcomes and expand their market presence.

  • Growing Demand For Rapid And Accurate Diagnostic Tests: The increasing need for quick, reliable diagnostic tools in veterinary medicine is a major growth driver. Advances in point-of-care testing and molecular diagnostics enable early disease detection, improving treatment outcomes. Rising pet ownership and awareness of zoonotic diseases also contribute to this demand. Companies are investing in innovative technologies to meet these needs, expanding the market for animal IVD products and services.
  • Expansion Of Companion Animal Diagnostics Market: The rising number of pet owners worldwide is fueling demand for diagnostic solutions tailored to companion animals. Owners seek comprehensive health assessments, disease screening, and preventive care. Veterinary clinics are adopting advanced IVD tools to improve diagnostics, leading to increased sales and product development. This expansion is supported by increased awareness of pet health and the need for early intervention, creating significant growth opportunities.
  • Increasing Adoption Of Molecular Diagnostic Techniques: Molecular diagnostics offer high sensitivity and specificity for detecting infectious diseases, genetic disorders, and cancers in animals. The adoption of PCR, next-generation sequencing, and other molecular methods is rising due to their accuracy and speed. Veterinary laboratories and clinics are integrating these techniques into routine diagnostics, which enhances disease management and control. This trend is expected to continue, driving innovation and market growth.
  • Rising Focus On Personalized Veterinary Medicine: Personalized medicine in veterinary care involves tailoring treatments based on genetic, biochemical, and diagnostic data. The use of IVD tools to identify specific biomarkers enables targeted therapies, improving efficacy and reducing side effects. This approach is gaining traction among veterinary practitioners and pet owners seeking advanced care options. The development of companion diagnostics and precision medicine is opening new revenue streams and expanding the scope of animal IVD applications.
  • Increasing Investment In Veterinary Diagnostic Startups And Collaborations: Venture capital and corporate investments are fueling innovation in the animal IVD sector. Startups are developing novel diagnostic platforms, while collaborations between biotech firms and veterinary clinics accelerate product commercialization. These investments support research, regulatory approvals, and market expansion efforts. As a result, the industry is witnessing rapid technological advancements and increased market competitiveness, which will further drive growth and adoption of advanced diagnostic solutions.

The overall impact of these opportunities is a robust, innovative, and expanding animal IVD market. Stakeholders can capitalize on technological advancements, rising pet health awareness, and strategic collaborations to enhance market share. This growth will improve diagnostic accuracy, enable personalized treatments, and ultimately lead to better health outcomes for animals, fostering long-term industry sustainability and profitability.

Animal IVD Market Driver and Challenges

The animal IVD market is influenced by a complex interplay of technological advancements, economic factors, and regulatory frameworks. Rapid innovations in diagnostic technologies, increasing adoption of point-of-care testing, and rising demand for early disease detection are key drivers propelling market growth. Economic factors such as rising animal healthcare expenditure and increasing prevalence of animal diseases further stimulate market expansion. Additionally, stringent regulatory standards and the need for accurate, rapid diagnostics pose both opportunities and challenges. Understanding these drivers and challenges is essential for stakeholders aiming to capitalize on market potential while navigating regulatory and technological hurdles.

The factors responsible for driving the animal IVD market include:

  • Technological Innovation: The development of advanced diagnostic tools such as multiplex assays, molecular diagnostics, and portable testing devices significantly enhances the accuracy, speed, and ease of animal disease detection. These innovations enable early diagnosis, improving treatment outcomes and reducing economic losses for farmers and pet owners. Continuous R&D investments foster the creation of more sensitive and specific tests, expanding market opportunities. Moreover, integration with digital health platforms allows for real-time data sharing and remote monitoring, further boosting adoption rates. As technology evolves, the market is expected to see increased demand for user-friendly, cost-effective diagnostic solutions, driving overall growth.
  • Rising Prevalence of Animal Diseases: The increasing incidence of infectious and chronic diseases in animals, such as avian influenza, foot-and-mouth disease, and parasitic infections, necessitates reliable diagnostic tools. The growing awareness among pet owners and livestock farmers about disease management and prevention fuels demand for accurate testing. Governments and veterinary organizations are emphasizing disease control programs, which require efficient diagnostic solutions. This trend not only supports the expansion of diagnostic testing but also encourages the development of targeted tests for emerging diseases. Consequently, the rising disease burden directly correlates with increased market demand for comprehensive IVD solutions.
  • Growing Pet Ownership and Companion Animal Care: The surge in pet ownership globally, especially in developed countries, has led to increased expenditure on pet healthcare. Owners are more proactive about regular health check-ups and disease screening, which drives demand for veterinary diagnostic tests. The rising awareness about zoonotic diseases and the importance of early detection further amplifies this trend. Veterinary clinics and hospitals are adopting advanced diagnostic tools to provide better care, creating a robust market for IVD products. This demographic shift towards responsible pet ownership is a significant factor fueling market growth, with an emphasis on non-invasive, rapid, and accurate testing methods.
  • Increasing Investment and Strategic Collaborations: The market benefits from substantial investments by pharmaceutical companies, biotech firms, and venture capitalists aiming to develop innovative diagnostic solutions. Strategic collaborations between diagnostic companies and veterinary healthcare providers facilitate product development, commercialization, and distribution. These partnerships enable access to new markets and foster technological advancements. Additionally, government grants and funding initiatives support research activities, accelerating innovation. The influx of capital and strategic alliances enhances product pipelines and market reach, ultimately driving growth and competitiveness within the Animal IVD sector.
  • Regulatory Developments and Market Expansion: Evolving regulatory standards aimed at ensuring the safety, efficacy, and quality of diagnostic products influence market dynamics. Stringent approval processes can pose challenges but also ensure high-quality offerings, boosting consumer confidence. Regulatory harmonization across regions facilitates international trade and market expansion. Governments are implementing policies to promote veterinary diagnostics, including subsidies and incentives, which encourage adoption. Compliance with regulatory requirements also spurs innovation, leading to the development of more reliable and standardized tests. Overall, regulatory frameworks shape market growth by balancing innovation with safety and quality assurance.

The challenges facing the animal IVD market include:

  • High Cost of Advanced Diagnostic Technologies: The adoption of sophisticated diagnostic tools often involves significant investment in equipment, reagents, and training. Small veterinary clinics and livestock farmers may find these costs prohibitive, limiting market penetration in developing regions. Additionally, the high cost can impact the affordability of tests for end-users, reducing accessibility and slowing adoption rates. Manufacturers face the challenge of balancing technological sophistication with cost-effectiveness to expand their customer base. Overcoming this barrier requires innovation in manufacturing processes and strategic pricing models to make advanced diagnostics more accessible across diverse economic settings.
  • Regulatory Complexity and Approval Delays: Navigating the complex regulatory landscape for veterinary diagnostics can be time-consuming and costly. Different regions have varying standards and approval procedures, which can delay product launches and increase compliance costs. Lengthy approval timelines may hinder rapid market entry for innovative products, affecting competitiveness. Moreover, evolving regulations require continuous updates and re-evaluation of existing products, adding to operational challenges. Companies must invest in regulatory expertise and adapt to changing standards to ensure timely approval, which can be resource-intensive and impact overall market growth.
  • Limited Awareness and Accessibility in Emerging Markets: Despite growth potential, many developing regions face challenges related to awareness, infrastructure, and access to veterinary diagnostic services. Lack of trained personnel and inadequate healthcare infrastructure hinder the effective deployment of IVD solutions. Additionally, limited awareness among farmers and pet owners about the benefits of early diagnosis restricts demand. Addressing these issues requires targeted educational campaigns, capacity building, and infrastructure development. Without these efforts, market expansion in emerging economies may remain constrained, limiting the global reach of advanced veterinary diagnostics.

The animal IVD market is driven by technological innovations, rising disease prevalence, increasing pet ownership, strategic investments, and supportive regulatory developments. However, high costs, regulatory hurdles, and limited awareness in emerging markets pose significant challenges. These factors collectively influence the pace and scope of market growth. While technological advancements and regulatory support foster expansion, economic barriers and awareness gaps may slow progress in certain regions. Overall, the markets future depends on balancing innovation with affordability and accessibility, ensuring sustainable growth and improved animal health worldwide.

List of Animal IVD Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies animal IVD companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the animal IVD companies profiled in this report include-

  • Heska
  • Zoetis
  • Antech
  • Eurofins Ingenasa
  • IDEXX
  • Bio-Rad
  • Thermo Fisher Scientific
  • Randox
  • Idvet
  • Edan Instruments

Animal IVD Market by Segment

The study includes a forecast for the global animal IVD market by type, application, and region.

Animal IVD Market by Type [Value from 2019 to 2035]:

  • Immunodiagnosis
  • Clinical Biochemistry & Molecular Diagnosis
  • Hematology
  • Others

Animal IVD Market by Application [Value from 2019 to 2035]:

  • Pet Hospital
  • Animal Husbandry & Veterinary System
  • Zoo
  • Research Institute Animal Experiment Center
  • Animal & Plant Quarantine Department
  • Others

Animal IVD Market by Region [Value from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Animal IVD Market

The animal IVD market has experienced significant growth driven by advancements in veterinary medicine, increasing pet ownership, and the need for early disease detection in animals. Technological innovations, regulatory approvals, and expanding applications in disease management are shaping the landscape across major markets. The United States, China, Germany, India, and Japan are key players, each contributing unique developments that influence global trends. These countries are investing in research, expanding product portfolios, and adopting new diagnostic technologies to improve animal health outcomes and meet rising demand for veterinary diagnostics.

  • United States: The US animal IVD market is rapidly expanding due to increased pet ownership and a focus on early disease detection. Innovations in molecular diagnostics and point-of-care testing are gaining traction. Regulatory agencies like the FDA are streamlining approval processes, encouraging new product launches. Companies are investing heavily in R&D to develop advanced diagnostic tools for infectious diseases, cancer, and genetic disorders in animals. The market also benefits from a well-established veterinary healthcare infrastructure and rising awareness among pet owners about animal health. Telemedicine integration is further enhancing diagnostic accessibility and efficiency.
  • China: China's animal IVD market is witnessing robust growth driven by rising disposable incomes and increasing pet adoption. The government's focus on animal health and welfare has led to supportive policies and investments in veterinary infrastructure. Local companies are expanding their product offerings, including rapid diagnostic kits and molecular testing solutions. The adoption of advanced technologies such as PCR and ELISA is increasing, especially in urban centers. Additionally, the growing prevalence of zoonotic diseases has spurred demand for reliable diagnostic tools. Collaborations with international firms are facilitating technology transfer and innovation, positioning China as a key emerging market.
  • Germany: Germany remains a leader in the European animal IVD market, characterized by high veterinary healthcare standards and technological innovation. The market is driven by a strong emphasis on disease prevention and health management in companion animals and livestock. Companies are focusing on developing sensitive, rapid, and user-friendly diagnostic tests. Regulatory frameworks in the EU ensure product safety and efficacy, fostering trust among users. Germany's integration of digital health solutions and laboratory automation is enhancing diagnostic accuracy and workflow efficiency. The country also emphasizes sustainable and eco-friendly diagnostic products, aligning with broader environmental goals.
  • India: The Indian animal IVD market is experiencing rapid growth due to increasing awareness of animal health and rising pet ownership. The expanding livestock sector is also a significant driver, with a focus on disease control and productivity enhancement. Local manufacturers are introducing affordable diagnostic kits tailored to regional needs, including tests for prevalent zoonotic diseases. The government's initiatives to improve veterinary healthcare infrastructure and disease surveillance are boosting market prospects. Technological adoption, such as portable and rapid testing devices, is increasing in rural and semi-urban areas. Collaborations with global firms are helping to introduce innovative diagnostic solutions to the Indian market.
  • Japan: Japan's animal IVD market is characterized by high technological adoption and a focus on advanced diagnostics for companion animals and livestock. The aging pet population has increased demand for health monitoring and disease management solutions. Japan's stringent regulatory environment ensures high-quality standards for diagnostic products. Companies are investing in research to develop personalized veterinary diagnostics and molecular testing methods. The integration of AI and data analytics is improving diagnostic accuracy and treatment planning. Japan also emphasizes sustainable and environmentally friendly diagnostic products, aligning with its broader environmental policies. The market continues to evolve with innovations in digital health and telemedicine for veterinary care.

Features of the Global Animal IVD Market

  • Market Size Estimates: Animal IVD market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
  • Segmentation Analysis: Animal IVD market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Animal IVD market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the animal IVD market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the animal IVD market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the animal IVD market by type (immunodiagnosis, clinical biochemistry & molecular diagnosis, hematology, and others), application (pet hospital, animal husbandry & veterinary system, zoo, research institute animal experiment center, animal & plant quarantine department, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Animal IVD Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Immunodiagnosis : Trends and Forecast (2019-2035)
  • 4.4 Clinical Biochemistry & Molecular Diagnosis : Trends and Forecast (2019-2035)
  • 4.5 Hematology : Trends and Forecast (2019-2035)
  • 4.6 Others : Trends and Forecast (2019-2035)

5. Global Animal IVD Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Pet Hospital : Trends and Forecast (2019-2035)
  • 5.4 Animal Husbandry & Veterinary System : Trends and Forecast (2019-2035)
  • 5.5 Zoo : Trends and Forecast (2019-2035)
  • 5.6 Research Institute Animal Experiment Center : Trends and Forecast (2019-2035)
  • 5.7 Animal & Plant Quarantine Department : Trends and Forecast (2019-2035)
  • 5.8 Others : Trends and Forecast (2019-2035)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Animal IVD Market by Region

7. North American Animal IVD Market

  • 7.1 Overview
  • 7.2 North American Animal IVD Market by Type
  • 7.3 North American Animal IVD Market by Application
  • 7.4 The United States Animal IVD Market
  • 7.5 Canadian Animal IVD Market
  • 7.6 Mexican Animal IVD Market

8. European Animal IVD Market

  • 8.1 Overview
  • 8.2 European Animal IVD Market by Type
  • 8.3 European Animal IVD Market by Application
  • 8.4 German Animal IVD Market
  • 8.5 French Animal IVD Market
  • 8.6 Italian Animal IVD Market
  • 8.7 Spanish Animal IVD Market
  • 8.8 The United Kingdom Animal IVD Market

9. APAC Animal IVD Market

  • 9.1 Overview
  • 9.2 APAC Animal IVD Market by Type
  • 9.3 APAC Animal IVD Market by Application
  • 9.4 Chinese Animal IVD Market
  • 9.5 Indian Animal IVD Market
  • 9.6 Japanese Animal IVD Market
  • 9.7 South Korean Animal IVD Market
  • 9.8 Indonesian Animal IVD Market

10. ROW Animal IVD Market

  • 10.1 Overview
  • 10.2 ROW Animal IVD Market by Type
  • 10.3 ROW Animal IVD Market by Application
  • 10.4 Middle Eastern Animal IVD Market
  • 10.5 South American Animal IVD Market
  • 10.6 African Animal IVD Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunity by Type
    • 12.2.2 Growth Opportunity by Application
  • 12.3 Emerging Trends in the Global Animal IVD Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis Overview
  • 13.2 Heska
    • Company Overview
    • Animal IVD Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Zoetis
    • Company Overview
    • Animal IVD Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Antech
    • Company Overview
    • Animal IVD Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Eurofins Ingenasa
    • Company Overview
    • Animal IVD Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 IDEXX
    • Company Overview
    • Animal IVD Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Bio-Rad
    • Company Overview
    • Animal IVD Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Thermo Fisher Scientific
    • Company Overview
    • Animal IVD Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Randox
    • Company Overview
    • Animal IVD Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Idvet
    • Company Overview
    • Animal IVD Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Edan Instruments
    • Company Overview
    • Animal IVD Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Animal IVD Market
  • Figure 2.1: Usage of Animal IVD Market
  • Figure 2.2: Classification of the Global Animal IVD Market
  • Figure 2.3: Supply Chain of the Global Animal IVD Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the Animal IVD Market
  • Figure 4.1: Global Animal IVD Market by Type in 2019, 2025, and 2035
  • Figure 4.2: Trends of the Global Animal IVD Market ($B) by Type
  • Figure 4.3: Forecast for the Global Animal IVD Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Immunodiagnosis in the Global Animal IVD Market (2019-2035)
  • Figure 4.5: Trends and Forecast for Clinical Biochemistry & Molecular Diagnosis in the Global Animal IVD Market (2019-2035)
  • Figure 4.6: Trends and Forecast for Hematology in the Global Animal IVD Market (2019-2035)
  • Figure 4.7: Trends and Forecast for Others in the Global Animal IVD Market (2019-2035)
  • Figure 5.1: Global Animal IVD Market by Application in 2019, 2025, and 2035
  • Figure 5.2: Trends of the Global Animal IVD Market ($B) by Application
  • Figure 5.3: Forecast for the Global Animal IVD Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Pet Hospital in the Global Animal IVD Market (2019-2035)
  • Figure 5.5: Trends and Forecast for Animal Husbandry & Veterinary System in the Global Animal IVD Market (2019-2035)
  • Figure 5.6: Trends and Forecast for Zoo in the Global Animal IVD Market (2019-2035)
  • Figure 5.7: Trends and Forecast for Research Institute Animal Experiment Center in the Global Animal IVD Market (2019-2035)
  • Figure 5.8: Trends and Forecast for Animal & Plant Quarantine Department in the Global Animal IVD Market (2019-2035)
  • Figure 5.9: Trends and Forecast for Others in the Global Animal IVD Market (2019-2035)
  • Figure 6.1: Trends of the Global Animal IVD Market ($B) by Region (2019-2025)
  • Figure 6.2: Forecast for the Global Animal IVD Market ($B) by Region (2026-2035)
  • Figure 7.1: Trends and Forecast for the North American Animal IVD Market (2019-2035)
  • Figure 7.2: North American Animal IVD Market by Type in 2019, 2025, and 2035
  • Figure 7.3: Trends of the North American Animal IVD Market ($B) by Type (2019-2025)
  • Figure 7.4: Forecast for the North American Animal IVD Market ($B) by Type (2026-2035)
  • Figure 7.5: North American Animal IVD Market by Application in 2019, 2025, and 2035
  • Figure 7.6: Trends of the North American Animal IVD Market ($B) by Application (2019-2025)
  • Figure 7.7: Forecast for the North American Animal IVD Market ($B) by Application (2026-2035)
  • Figure 7.8: Trends and Forecast for the United States Animal IVD Market ($B) (2019-2035)
  • Figure 7.9: Trends and Forecast for the Mexican Animal IVD Market ($B) (2019-2035)
  • Figure 7.10: Trends and Forecast for the Canadian Animal IVD Market ($B) (2019-2035)
  • Figure 8.1: Trends and Forecast for the European Animal IVD Market (2019-2035)
  • Figure 8.2: European Animal IVD Market by Type in 2019, 2025, and 2035
  • Figure 8.3: Trends of the European Animal IVD Market ($B) by Type (2019-2025)
  • Figure 8.4: Forecast for the European Animal IVD Market ($B) by Type (2026-2035)
  • Figure 8.5: European Animal IVD Market by Application in 2019, 2025, and 2035
  • Figure 8.6: Trends of the European Animal IVD Market ($B) by Application (2019-2025)
  • Figure 8.7: Forecast for the European Animal IVD Market ($B) by Application (2026-2035)
  • Figure 8.8: Trends and Forecast for the German Animal IVD Market ($B) (2019-2035)
  • Figure 8.9: Trends and Forecast for the French Animal IVD Market ($B) (2019-2035)
  • Figure 8.10: Trends and Forecast for the Spanish Animal IVD Market ($B) (2019-2035)
  • Figure 8.11: Trends and Forecast for the Italian Animal IVD Market ($B) (2019-2035)
  • Figure 8.12: Trends and Forecast for the United Kingdom Animal IVD Market ($B) (2019-2035)
  • Figure 9.1: Trends and Forecast for the APAC Animal IVD Market (2019-2035)
  • Figure 9.2: APAC Animal IVD Market by Type in 2019, 2025, and 2035
  • Figure 9.3: Trends of the APAC Animal IVD Market ($B) by Type (2019-2025)
  • Figure 9.4: Forecast for the APAC Animal IVD Market ($B) by Type (2026-2035)
  • Figure 9.5: APAC Animal IVD Market by Application in 2019, 2025, and 2035
  • Figure 9.6: Trends of the APAC Animal IVD Market ($B) by Application (2019-2025)
  • Figure 9.7: Forecast for the APAC Animal IVD Market ($B) by Application (2026-2035)
  • Figure 9.8: Trends and Forecast for the Japanese Animal IVD Market ($B) (2019-2035)
  • Figure 9.9: Trends and Forecast for the Indian Animal IVD Market ($B) (2019-2035)
  • Figure 9.10: Trends and Forecast for the Chinese Animal IVD Market ($B) (2019-2035)
  • Figure 9.11: Trends and Forecast for the South Korean Animal IVD Market ($B) (2019-2035)
  • Figure 9.12: Trends and Forecast for the Indonesian Animal IVD Market ($B) (2019-2035)
  • Figure 10.1: Trends and Forecast for the ROW Animal IVD Market (2019-2035)
  • Figure 10.2: ROW Animal IVD Market by Type in 2019, 2025, and 2035
  • Figure 10.3: Trends of the ROW Animal IVD Market ($B) by Type (2019-2025)
  • Figure 10.4: Forecast for the ROW Animal IVD Market ($B) by Type (2026-2035)
  • Figure 10.5: ROW Animal IVD Market by Application in 2019, 2025, and 2035
  • Figure 10.6: Trends of the ROW Animal IVD Market ($B) by Application (2019-2025)
  • Figure 10.7: Forecast for the ROW Animal IVD Market ($B) by Application (2026-2035)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Animal IVD Market ($B) (2019-2035)
  • Figure 10.9: Trends and Forecast for the South American Animal IVD Market ($B) (2019-2035)
  • Figure 10.10: Trends and Forecast for the African Animal IVD Market ($B) (2019-2035)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Animal IVD Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Animal IVD Market (2025)
  • Figure 12.1: Growth Opportunities for the Global Animal IVD Market by Type
  • Figure 12.2: Growth Opportunities for the Global Animal IVD Market by Application
  • Figure 12.3: Growth Opportunities for the Global Animal IVD Market by Region
  • Figure 12.4: Emerging Trends in the Global Animal IVD Market

List of Tables

  • Table 1.1: Growth Rate (%, 2024-2025) and CAGR (%, 2026-2035) of the Animal IVD Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Animal IVD Market by Region
  • Table 1.3: Global Animal IVD Market Parameters and Attributes
  • Table 3.1: Trends of the Global Animal IVD Market (2019-2025)
  • Table 3.2: Forecast for the Global Animal IVD Market (2026-2035)
  • Table 4.1: Attractiveness Analysis for the Global Animal IVD Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Animal IVD Market (2019-2025)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Animal IVD Market (2026-2035)
  • Table 4.4: Trends of Immunodiagnosis in the Global Animal IVD Market (2019-2025)
  • Table 4.5: Forecast for Immunodiagnosis in the Global Animal IVD Market (2026-2035)
  • Table 4.6: Trends of Clinical Biochemistry & Molecular Diagnosis in the Global Animal IVD Market (2019-2025)
  • Table 4.7: Forecast for Clinical Biochemistry & Molecular Diagnosis in the Global Animal IVD Market (2026-2035)
  • Table 4.8: Trends of Hematology in the Global Animal IVD Market (2019-2025)
  • Table 4.9: Forecast for Hematology in the Global Animal IVD Market (2026-2035)
  • Table 4.10: Trends of Others in the Global Animal IVD Market (2019-2025)
  • Table 4.11: Forecast for Others in the Global Animal IVD Market (2026-2035)
  • Table 5.1: Attractiveness Analysis for the Global Animal IVD Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Animal IVD Market (2019-2025)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Animal IVD Market (2026-2035)
  • Table 5.4: Trends of Pet Hospital in the Global Animal IVD Market (2019-2025)
  • Table 5.5: Forecast for Pet Hospital in the Global Animal IVD Market (2026-2035)
  • Table 5.6: Trends of Animal Husbandry & Veterinary System in the Global Animal IVD Market (2019-2025)
  • Table 5.7: Forecast for Animal Husbandry & Veterinary System in the Global Animal IVD Market (2026-2035)
  • Table 5.8: Trends of Zoo in the Global Animal IVD Market (2019-2025)
  • Table 5.9: Forecast for Zoo in the Global Animal IVD Market (2026-2035)
  • Table 5.10: Trends of Research Institute Animal Experiment Center in the Global Animal IVD Market (2019-2025)
  • Table 5.11: Forecast for Research Institute Animal Experiment Center in the Global Animal IVD Market (2026-2035)
  • Table 5.12: Trends of Animal & Plant Quarantine Department in the Global Animal IVD Market (2019-2025)
  • Table 5.13: Forecast for Animal & Plant Quarantine Department in the Global Animal IVD Market (2026-2035)
  • Table 5.14: Trends of Others in the Global Animal IVD Market (2019-2025)
  • Table 5.15: Forecast for Others in the Global Animal IVD Market (2026-2035)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Animal IVD Market (2019-2025)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Animal IVD Market (2026-2035)
  • Table 7.1: Trends of the North American Animal IVD Market (2019-2025)
  • Table 7.2: Forecast for the North American Animal IVD Market (2026-2035)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Animal IVD Market (2019-2025)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Animal IVD Market (2026-2035)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Animal IVD Market (2019-2025)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Animal IVD Market (2026-2035)
  • Table 7.7: Trends and Forecast for the United States Animal IVD Market (2019-2035)
  • Table 7.8: Trends and Forecast for the Mexican Animal IVD Market (2019-2035)
  • Table 7.9: Trends and Forecast for the Canadian Animal IVD Market (2019-2035)
  • Table 8.1: Trends of the European Animal IVD Market (2019-2025)
  • Table 8.2: Forecast for the European Animal IVD Market (2026-2035)
  • Table 8.3: Market Size and CAGR of Various Type in the European Animal IVD Market (2019-2025)
  • Table 8.4: Market Size and CAGR of Various Type in the European Animal IVD Market (2026-2035)
  • Table 8.5: Market Size and CAGR of Various Application in the European Animal IVD Market (2019-2025)
  • Table 8.6: Market Size and CAGR of Various Application in the European Animal IVD Market (2026-2035)
  • Table 8.7: Trends and Forecast for the German Animal IVD Market (2019-2035)
  • Table 8.8: Trends and Forecast for the French Animal IVD Market (2019-2035)
  • Table 8.9: Trends and Forecast for the Spanish Animal IVD Market (2019-2035)
  • Table 8.10: Trends and Forecast for the Italian Animal IVD Market (2019-2035)
  • Table 8.11: Trends and Forecast for the United Kingdom Animal IVD Market (2019-2035)
  • Table 9.1: Trends of the APAC Animal IVD Market (2019-2025)
  • Table 9.2: Forecast for the APAC Animal IVD Market (2026-2035)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Animal IVD Market (2019-2025)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Animal IVD Market (2026-2035)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Animal IVD Market (2019-2025)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Animal IVD Market (2026-2035)
  • Table 9.7: Trends and Forecast for the Japanese Animal IVD Market (2019-2035)
  • Table 9.8: Trends and Forecast for the Indian Animal IVD Market (2019-2035)
  • Table 9.9: Trends and Forecast for the Chinese Animal IVD Market (2019-2035)
  • Table 9.10: Trends and Forecast for the South Korean Animal IVD Market (2019-2035)
  • Table 9.11: Trends and Forecast for the Indonesian Animal IVD Market (2019-2035)
  • Table 10.1: Trends of the ROW Animal IVD Market (2019-2025)
  • Table 10.2: Forecast for the ROW Animal IVD Market (2026-2035)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Animal IVD Market (2019-2025)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Animal IVD Market (2026-2035)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Animal IVD Market (2019-2025)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Animal IVD Market (2026-2035)
  • Table 10.7: Trends and Forecast for the Middle Eastern Animal IVD Market (2019-2035)
  • Table 10.8: Trends and Forecast for the South American Animal IVD Market (2019-2035)
  • Table 10.9: Trends and Forecast for the African Animal IVD Market (2019-2035)
  • Table 11.1: Product Mapping of Animal IVD Suppliers Based on Segments
  • Table 11.2: Operational Integration of Animal IVD Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Animal IVD Revenue
  • Table 12.1: New Product Launches by Major Animal IVD Producers (2019-2025)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Animal IVD Market